Kioxia Corporation has expanded its high-capacity KIOXIA LC9 Series enterprise SSD lineup by introducing the industry’s first[1] 245.76 terabyte (TB)[2] NVMe™ SSD in 2.5-inch and EDSFF E3.L form factor. This new capacity and form factor option complements the previously announced 122.88 TB (2.5-inch) model and is purpose-built for the performance and efficiency demands of generative AI environments. This press release features multimedia. View the full release here: https://www.businesswire.co...

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the European Medicines Agency (EMA) has granted PRIority MEdicines (PRIME) designation to the Company’s investigational Bruton’s tyrosine kinase (BTK) degrader, BGB-16673, for the treatment of patients with Waldenstrom’s macroglobulinemia (WM) previously treated with a BTK inhibitor. “This is the Company’s first PRIME designation, marking a milestone for BeOne and providing early and ...

Payroc WorldAccess, LLC a leading North American merchant acquirer and payment technology provider, today announced the signing of a definitive agreement to acquire BlueSnap, a Boston-based global payment orchestration and AR automation platform. This strategic acquisition unites Payroc's direct-connect acquiring infrastructure across the U.S., Canada, and Puerto Rico, and transforms Payroc’s capabilities by adding BlueSnap’s robust global and enterprise capabilities. The transaction is expecte...

AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, is excited to announce that it has received medical device approval from the Thai Food and Drug Administration (Thai FDA) on June 26, 2025. The approval is for its endoscopic image diagnosis support software, the "gastroAI-model G." This system utilizes artificial intelligence to assist physicians in differentiating between neoplastic and non-neoplastic gastric lesions with...

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issued a positive opinion recommending approval of TEVIMBRA® (tislelizumab), in combination with platinum-containing chemotherapy as neoadjuvant treatment and then continued as monotherapy as adjuvant treatment, for the treatment of adult patients with resectable non-small cell lung cancer (NSCLC)...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the second quarter 2025 and provided an update on recent progress across its business. “With the recent positive 6-week primary endpoint from our first COMP360 Phase 3 study and the prior positive Phase 2b study, we have now delivered clinically meaningful and highly statistically significant top-line resu...

As part of its global product launch event “Infinite Power – Starting from Zero,” Autel Energy introduced a high-power charging system from the MaxiCharger DT1000 series, integrating Phoenix Contact’s latest 1,000A liquid-cooled CCS Type 2 cable and connector system. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909054584/en/Autel Energy showcased the MaxiCharger DT1000 terminal integrating Phoenix Contact’s latest liquid-cooled...

Sisvel has appointed Yixiong Zou to lead its operations in China. He will be responsible for steering the company’s licensing, programme management and business development efforts in the country, and will manage a new Sisvel office to be established in Shenzhen. Mr Zou joins the company as Managing Director, China and is the first person to hold this title. His appointment reflects the importance that Sisvel attaches to the Chinese market. In a career spanning more than 25 years, Mr Zou ha...